This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Uyanga Tsedev
Founder & Chief Scientific Officer at Gensaic
Speaker

Profile

Dr. Uyanga Tsedev is a biomaterials engineer with broad interest in protein assemblies and manipulation of genetically encoded materials. As co-founder and CSO at Gensaic, Dr. Tsedev drives the discovery of functional sequences and the AI-guided evolution of protein structures for oligonucleotide delivery. She received her PhD in Biological Engineering from MIT, building genetically modified phage-like particles for localized delivery of DNA and small molecules in cancer models at the Koch Institute. Her MS in Mechanical Engineering was also completed at MIT, researching biological scaffolds for nanoscale materials templating. Before coming to MIT, Dr. Tsedev obtained her BS at Harvard University, where she worked on bioresponsive drug delivery and tissue engineering technologies with groups at the Wyss Institute and Beth Israel Deaconess Medical Center.